Found: 26
Select item for more details and to access through your institution.
Mobile Apps for Hematological Conditions: Review and Content Analysis Using the Mobile App Rating Scale.
- Published in:
- JMIR mHealth & uHealth, 2022, v. 10, n. 2, p. 1, doi. 10.2196/32826
- By:
- Publication type:
- Article
Chimeric Antigen Receptor T Cell Therapy Management and Safety: A Practical Tool From a Multidisciplinary Team Perspective.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.636068
- By:
- Publication type:
- Article
Standardizing Health Outcomes for Lung Cancer. Adaptation of the International Consortium for Health Outcomes Measurement Set to the Spanish Setting.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. N.PAG, doi. 10.3389/fonc.2020.01645
- By:
- Publication type:
- Article
Features and Functionalities of Smartphone Apps Related to COVID-19: Systematic Search in App Stores and Content Analysis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Oncology Patient Interest in the Use of New Technologies to Manage Their Disease: Cross-Sectional Survey.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Economic burden of locoregional and metastatic relapses in resectable early-stage non-small cell lung cancer in Spain.
- Published in:
- BMC Pulmonary Medicine, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12890-023-02356-0
- By:
- Publication type:
- Article
Complementary and alternative medicine in cancer patients: characteristics of use and interactions with antineoplastic agents.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 7, p. 2855, doi. 10.1007/s00432-022-04172-1
- By:
- Publication type:
- Article
Oral antineoplastic agent interactions with medicinal plants and food: an issue to take into account.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2016, v. 142, n. 11, p. 2319, doi. 10.1007/s00432-016-2190-8
- By:
- Publication type:
- Article
Novel mobile application for direct communication between pharmacists and patients treated with oral antineoplastic agents.
- Published in:
- American Journal of Health-System Pharmacy, 2020, v. 77, n. 17, p. 1393, doi. 10.1093/ajhp/zxaa144
- By:
- Publication type:
- Article
Effectiveness and Safety of Ombitasvir-Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin for HCV Genotype 1 Infection for 12 Weeks Under Routine Clinical Practice.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Possible heart failure caused by osimertinib in a lung cancer patient.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 4, p. 1015, doi. 10.1177/10781552221143787
- By:
- Publication type:
- Article
Potential negative pharmacodynamic interaction of spironolactone and abiraterone in two prostate cancer patients.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 5, p. 1259, doi. 10.1177/10781552221074621
- By:
- Publication type:
- Article
Acute pancreatitis in a patient treated with imatinib and gefitinib.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 4, p. 980, doi. 10.1177/1078155220949639
- By:
- Publication type:
- Article
Tocilizumab as salvage treatment of refractory pulmonary acute graft-versus-host disease.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 3, p. 751, doi. 10.1177/1078155220948934
- By:
- Publication type:
- Article
Design of the functional requirements of a smartphone app for patients receiving oral antineoplastic agents: The e-OncoSalud® app.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 1, p. 105, doi. 10.1177/1078155219840419
- By:
- Publication type:
- Article
Thalidomide as treatment of refractory thoracic Rosai‐Dorfman disease.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2022, v. 47, n. 4, p. 548, doi. 10.1111/jcpt.13513
- By:
- Publication type:
- Article
Smartphone-Based Ecological Momentary Assessment for the Measurement of the Performance Status and Health-Related Quality of Life in Cancer Patients Under Systemic Anticancer Therapies: Development and Acceptability of a Mobile App.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.880430
- By:
- Publication type:
- Article
Smartphone-Based Ecological Momentary Assessment for the Measurement of the Performance Status and Health-Related Quality of Life in Cancer Patients Under Systemic Anticancer Therapies: Development and Acceptability of a Mobile App.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.880430
- By:
- Publication type:
- Article
A New Methodology to Estimate Drug Cost Avoidance in Clinical Trials: Development and Application.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.889575
- By:
- Publication type:
- Article
Defining a Standard Set of Patient-Reported Outcomes for Patients With Advanced Ovarian Cancer.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.885910
- By:
- Publication type:
- Article
Implantación y evaluación de un modelo de atención farmacéutica domiciliaria mediante Telefarmacia.
- Published in:
- Farmacia Hospitalaria (1130-6343), 2022, v. 46, p. 36, doi. 10.7399/fh.13252
- By:
- Publication type:
- Article
Implantación de una metodología para evaluar patient-reported outcomes en pacientes con cáncer de pulmón: Protocolo del estudio PeOpLe (Patient-reported Outcomes in Lung cancer).
- Published in:
- Farmacia Hospitalaria (1130-6343), 2022, v. 46, n. 4, p. 265, doi. 10.7399/fh.11835
- By:
- Publication type:
- Article
Patient-reported outcomes y aplicaciones móviles. Revisión de su impacto en los resultados en salud de los pacientes.
- Published in:
- Farmacia Hospitalaria (1130-6343), 2022, v. 46, n. 3, p. 173, doi. 10.7399/fh.11830
- By:
- Publication type:
- Article
Cost of Venous Thromboembolic Disease in Patients with Lung Cancer: COSTECAT Study.
- Published in:
- International Journal of Environmental Research & Public Health, 2021, v. 18, n. 2, p. 394, doi. 10.3390/ijerph18020394
- By:
- Publication type:
- Article
Assessment of diarrhea as side effect of oral targeted antineoplastic agents in clinical practice.
- Published in:
- Supportive Care in Cancer, 2021, v. 29, n. 8, p. 4673, doi. 10.1007/s00520-021-06016-z
- By:
- Publication type:
- Article
Aggressiveness of end-of-life cancer care: what happens in clinical practice?
- Published in:
- 2021
- By:
- Publication type:
- journal article